Home Doctors Dr Venkata Sampath V

    Dr Venkata Sampath V

    Medical Oncologist


    7+ Years Experience

    D. M (MEDICAL ONCOLOGY), M. D(RADIATION ONCOLOGY), M. B. B. S

    Jubilee Hills, Hyderabad

    English, Hindi, Telugu

    MON-SAT

    Overview

    Dr. Venkata V Sampath: Experienced Medical Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar, Hyderabad.

    Dr. Venkata V Sampath a highly regarded Medical Oncologist with 9+ years of experience, practices at Apollo Hospitals Jubilee Hills in Hyderabad. Dr. Venkata V Sampath has completed his DM(Med. Onco.), MD, MBBS. He offers a wide range of services to address various conditions: Renal Cell Carcinoma, Bad Breath Halitosis Treatment, Ovarian cysts, Langerhans Cell Histiocytosis, Actinic keratosis, Gastric Cancer, malignant-melanoma, Acute Lymphoblastic Leukemia, Hairy cell leukemia, Cholangiocarcinoma.

    If you’re seeking Medical Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar areas of Hyderabad, Dr. Venkata V Sampath is the right choice for expert care and treatment of your Medical Oncology needs. Book an appointment today and experience top-notch medical care.

    Registration No: 53682

    Education

    American Society of Medical Oncology(ASCO)European Society of Medical Oncology(ESMO)AROI

    Experience

    Presently Working as Consultant Medical Oncology at Apollo Hospitals Jubileehills since last AssignmentAssistant Professor, Department of Medical Oncology, SVIMS, From August 2014 to August 2015Consultant Oncologist at Yashoda Hospital, Secunderabad from Augus 2015

    Special Interests

    Precision Oncology, Targeted therapy, Immuno oncology, Solid and Haematological malignancies, Breast cancer, Lung cancer, Ovarian cancer, Colon cancer, Prostate cancer, Stomach Cancer

    Research

    Clinical Research Experience: Phase III, Inoperable Gastric Cancer, Sub Investigator, SVIMS/2011, Completed 20 Case Studies at time of M. D & D. M in NIMS & SVIMS A Prospective, multicenter, randomised, double blinded, 2-parallel groups, phase 3 study to compare as first line therapy efficacy and safety of masitinib in combination with gemcitabine, to gemcitabine in combination with placebo, followed as second line treatment by masitnib in combination with Folfiri 3 versus placebo in combination with Folfiri 3 in the treatment of patients with non resectable locally advanced or metastatic pancreatic cancerA prospective multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masatinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients with metastatic colorectal cancer Papers Published: Clinico-pathological significance of HER 2 expression in gastric cancer: A retrospective study in Indian population- JCO 2013, ASCO Vol 31, No 15-Supplymentay May 20, 2013 Letter to editor South Asian J Cancer 2013 2: 192 Study of quality of life in brain tumor patients treated with three-dimensional conformal radiotherapy- JCO, 2010 ASCO Annual Meeting Proceedings( Post- Meeting Edition) Vol 28. No 15_ suppl ( May 20 supplement), 201: 2091

    Dr Venkata Sampath V

    Medical Oncologist

    7+ Years Experience

    D. M (MEDICAL ONCOLOGY), M. D(RADIATION ONCOLOGY), M. B. B. S

    English, Hindi, Telugu

    MON-SAT

    -

    Overview

    Dr. Venkata V Sampath: Experienced Medical Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar, Hyderabad.

    Dr. Venkata V Sampath a highly regarded Medical Oncologist with 9+ years of experience, practices at Apollo Hospitals Jubilee Hills in Hyderabad. Dr. Venkata V Sampath has completed his DM(Med. Onco.), MD, MBBS. He offers a wide range of services to address various conditions: Renal Cell Carcinoma, Bad Breath Halitosis Treatment, Ovarian cysts, Langerhans Cell Histiocytosis, Actinic keratosis, Gastric Cancer, malignant-melanoma, Acute Lymphoblastic Leukemia, Hairy cell leukemia, Cholangiocarcinoma.

    If you’re seeking Medical Oncologist in Ameerpet, Archana-Multispeciality-Hospital-Chanda-Nagar, Banjara-Hills, Challa-Hospital, Film-Nagar, Gudimalkapur, Hakimpet, Hi-Tech-City, Humayun-Nagar, Jawahar-Nagar areas of Hyderabad, Dr. Venkata V Sampath is the right choice for expert care and treatment of your Medical Oncology needs. Book an appointment today and experience top-notch medical care.

    Registration No: 53682

    Education

    American Society of Medical Oncology(ASCO)European Society of Medical Oncology(ESMO)AROI

    Experience

    Presently Working as Consultant Medical Oncology at Apollo Hospitals Jubileehills since last AssignmentAssistant Professor, Department of Medical Oncology, SVIMS, From August 2014 to August 2015Consultant Oncologist at Yashoda Hospital, Secunderabad from Augus 2015

    Special Interests

    Precision Oncology, Targeted therapy, Immuno oncology, Solid and Haematological malignancies, Breast cancer, Lung cancer, Ovarian cancer, Colon cancer, Prostate cancer, Stomach Cancer

    Research

    Clinical Research Experience: Phase III, Inoperable Gastric Cancer, Sub Investigator, SVIMS/2011, Completed 20 Case Studies at time of M. D & D. M in NIMS & SVIMS A Prospective, multicenter, randomised, double blinded, 2-parallel groups, phase 3 study to compare as first line therapy efficacy and safety of masitinib in combination with gemcitabine, to gemcitabine in combination with placebo, followed as second line treatment by masitnib in combination with Folfiri 3 versus placebo in combination with Folfiri 3 in the treatment of patients with non resectable locally advanced or metastatic pancreatic cancerA prospective multicenter, randomized, double blind, placebo-controlled, 2-parallel groups, phase 3 study to compare the efficacy and safety of masatinib in combination with FOLFIRI (irinotecan, 5-fluorouracil and folinic acid) to placebo in combination with FOLFIRI in second line treatment of patients with metastatic colorectal cancer Papers Published: Clinico-pathological significance of HER 2 expression in gastric cancer: A retrospective study in Indian population- JCO 2013, ASCO Vol 31, No 15-Supplymentay May 20, 2013 Letter to editor South Asian J Cancer 2013 2: 192 Study of quality of life in brain tumor patients treated with three-dimensional conformal radiotherapy- JCO, 2010 ASCO Annual Meeting Proceedings( Post- Meeting Edition) Vol 28. No 15_ suppl ( May 20 supplement), 201: 2091

    '
    Book ProHealth Book Appointment

    Request A Call Back

    Close
    © Copyright 2024. Apollo Hospitals Group. All Rights Reserved.